<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01186965</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00022132</org_study_id>
    <secondary_id>R21LM010727-02</secondary_id>
    <nct_id>NCT01186965</nct_id>
  </id_info>
  <brief_title>Ehealth: Second Life Impacts Diabetes Education &amp; Self-Management</brief_title>
  <acronym>SLIDES</acronym>
  <official_title>Ehealth: Second Life Impacts Diabetes Education &amp; Self-Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to to develop and evaluate the feasibility, usability, and
      effect of participation in SLIDES (a virtual diabetes community in Second Life) for providing
      interactive diabetes education, support, and resources.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceived Usefulness</measure>
    <time_frame>3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perceived Ease of Use</measure>
    <time_frame>3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Process data</measure>
    <time_frame>January 2011 through May 2012</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demographics</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic Indicators</measure>
    <time_frame>baseline, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes knowledge</measure>
    <time_frame>baseline, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Type 2 Diabetes</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>eHealth program in the Virtual Environment (VE) platform Second Life</intervention_name>
    <description>determine the feasibility and acceptability of an eHealth program that provides diabetes education and self-management support.</description>
    <other_name>Second Life</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  current Duke Endocrinology patient

          -  are between 21 and 75 years old

          -  are able to speak and read English

          -  are computer literate (have used a computer for at least 6 months)

          -  understand how to use the Internet (have accessed the Internet on at least 6
             occasions)

          -  have access to a computer with a non-dial-up Internet connection in a private location
             (home)

          -  are mentally capable of informed consent

          -  are reachable by telephone

          -  have no pre-existing medical condition(s) or severe diabetes related complications
             that would interfere with study participation (i.e., physical activity) or measures
             (e.g., renal failure, Stage III hypertension, severe orthopedic conditions or joint
             replacement scheduled within 6 months, paralysis, bleeding disorders, cancer, or
             receipt of pharmacologic doses of anti-coagulant medications [warfarin])

          -  are able to travel to Duke University Medical Center (DUMC) for follow-up
             appointments.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Constance M Johnson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University School of Nursing</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2010</study_first_submitted>
  <study_first_submitted_qc>August 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2010</study_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Second Life</keyword>
  <keyword>virtual community</keyword>
  <keyword>diabetes education</keyword>
  <keyword>diabetes support group</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

